Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2− Advanced Breast Cancer

Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with... Adv Ther (2017) 34:2566–2584 DOI 10.1007/s12325-017-0644-2 REVIEW Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER22 Advanced Breast Cancer . . . . Zhou Zhou Derek H. Tang Jipan Xie Rajeev Ayyagari Eric Wu Polly A. Niravath Received: August 3, 2017 / Published online: November 16, 2017 Springer Healthcare Ltd., part of Springer Nature 2017 ET ? TT, and comparisons between the two ABSTRACT were summarized from the identified trials. Results: A total of 11 studies (representing 6 Introduction: A major treatment goal for RCTs) were identified. The study populations advanced breast cancer (ABC) is to maintain or included first-line (5 studies) and ET-failure ideally improve patient quality of life (QoL). settings (6 studies). Across settings, global Given the changing disease landscape, this sys- health status (GHS) maintained or deteriorated tematic literature review (SLR) aims to assess the slightly on these treatments during the trial impact of endocrine therapies (ET), including period. Time to deterioration (TTD) in QoL ET monotherapy (ET mono) and ET combined measured by GHS was analyzed in 6 studies and with targeted therapy (ET ? TT), on QoL of 4 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Advances in Therapy Springer Journals

Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER2− Advanced Breast Cancer

Loading next page...
 
/lp/springer_journal/systematic-literature-review-of-the-impact-of-endocrine-monotherapy-gfNziYat1g
Publisher
Springer Healthcare
Copyright
Copyright © 2017 by Springer Healthcare Ltd., part of Springer Nature
Subject
Medicine & Public Health; Internal Medicine; Oncology; Cardiology; Rheumatology; Endocrinology; Pharmacology/Toxicology
ISSN
0741-238X
eISSN
1865-8652
D.O.I.
10.1007/s12325-017-0644-2
Publisher site
See Article on Publisher Site

Abstract

Adv Ther (2017) 34:2566–2584 DOI 10.1007/s12325-017-0644-2 REVIEW Systematic Literature Review of the Impact of Endocrine Monotherapy and in Combination with Targeted Therapy on Quality of Life of Postmenopausal Women with HR+/HER22 Advanced Breast Cancer . . . . Zhou Zhou Derek H. Tang Jipan Xie Rajeev Ayyagari Eric Wu Polly A. Niravath Received: August 3, 2017 / Published online: November 16, 2017 Springer Healthcare Ltd., part of Springer Nature 2017 ET ? TT, and comparisons between the two ABSTRACT were summarized from the identified trials. Results: A total of 11 studies (representing 6 Introduction: A major treatment goal for RCTs) were identified. The study populations advanced breast cancer (ABC) is to maintain or included first-line (5 studies) and ET-failure ideally improve patient quality of life (QoL). settings (6 studies). Across settings, global Given the changing disease landscape, this sys- health status (GHS) maintained or deteriorated tematic literature review (SLR) aims to assess the slightly on these treatments during the trial impact of endocrine therapies (ET), including period. Time to deterioration (TTD) in QoL ET monotherapy (ET mono) and ET combined measured by GHS was analyzed in 6 studies and with targeted therapy (ET ? TT), on QoL of 4

Journal

Advances in TherapySpringer Journals

Published: Nov 16, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off